DNMT2 inhibits anaplastic thyroid cancer progression by downregulating 5'tiRNA&lt;sup&gt;Gly-GCC&lt;/sup&gt; production. This evidence concerns the gene TRDMT1 and thyroid gland undifferentiated (anaplastic) carcinoma.